tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
ProQR Therapeutics sees cash runway into mid-2027
PremiumThe FlyProQR Therapeutics sees cash runway into mid-2027
21d ago
ProQR Therapeutics price target raised to $5 from $4 at Evercore ISI
Premium
The Fly
ProQR Therapeutics price target raised to $5 from $4 at Evercore ISI
2M ago
ProQR Submits CTA for Phase 1 Study of AX-0810
Premium
Company Announcements
ProQR Submits CTA for Phase 1 Study of AX-0810
2M ago
ProQR Reports Q1 2025 Financial Results Amid Rising R&D Costs
PremiumCompany AnnouncementsProQR Reports Q1 2025 Financial Results Amid Rising R&D Costs
4M ago
ProQR Therapeutics reports Q1 EPS (EUR 0.10) vs (EUR 0.09) last year
Premium
The Fly
ProQR Therapeutics reports Q1 EPS (EUR 0.10) vs (EUR 0.09) last year
4M ago
PRQR Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
PRQR Upcoming Earnings Report: What to Expect?
4M ago
ProQR Therapeutics appoints Hom as CFO, Lopez as CMO
PremiumThe FlyProQR Therapeutics appoints Hom as CFO, Lopez as CMO
5M ago
ProQR Therapeutics Advances RNA Editing Pipeline
Premium
Company Announcements
ProQR Therapeutics Advances RNA Editing Pipeline
5M ago
ProQR’s Axiomer Technology and AX-0810: A Promising Buy Rating with Increased Price Target
Premium
Ratings
ProQR’s Axiomer Technology and AX-0810: A Promising Buy Rating with Increased Price Target
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100